Laddar...
Reversal Agents: What We Have and What We Can Expect
Clinical trials in patients with atrial fibrillation have demonstrated that non-vitamin K antagonist oral anticoagulants [novel oral anticoagulants (NOACs)] are markedly safer than warfarin with respect to serious bleeding—especially intracranial hemorrhage, the most feared and devastating complicat...
Sparad:
| I publikationen: | J Innov Card Rhythm Manag |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MediaSphere Medical
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7252789/ https://ncbi.nlm.nih.gov/pubmed/32477806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.19102/icrm.2018.090403 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|